Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

NCT04354831 PHASE2 COMPLETED Results posted

This is a Phase II study. This research study is being conducted to use convalescent donor plasma in seriously ill patients who have COVID-19.

Details

Lead sponsor	Medical College of Wisconsin
Phase	PHASE2
Status	COMPLETED
Enrolment	131
Start date	Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Feb 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• COVID-19

Interventions

• anti-SARS-CoV-2 convalescent plasma

Countries

United States